Quotation Dong, Di, Ozdemir, Semra, Bee, Yong Mong, Toh, Sue-Anne, Bilger, Marcel, Finkelstein, Eric. 2016. Measuring High-Risk Patients’ Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction: A Discrete Choice Experiment. Value in Health. 19 (6), 767-775.


RIS


BibTeX

Abstract

Objectives To investigate patient preferences and willingness to pay (WTP) for a genetic test that can reduce the risk of life-threatening adverse drug reactions (ADRs). We hypothesize that test features (risk of developing the adverse reaction with and without testing, test cost, and treatment cost) and the choice context (physician recommendation and the most common choice made by peer patients) will influence choices. Methods A discrete choice experiment was conducted in which 189 patients at high risk for gout were asked to choose between treatment options that varied along key attributes. A latent class logit model was used to analyze the choice data and test the hypotheses.

Tags

Press 'enter' for creating the tag

Publication's profile

Status of publication Published
Affiliation External
Type of publication Journal article
Journal Value in Health
Citation Index SSCI
WU-Journal-Rating new STRAT-B, WH-B
Language English
Title Measuring High-Risk Patients’ Preferences for Pharmacogenetic Testing to Reduce Severe Adverse Drug Reaction: A Discrete Choice Experiment
Volume 19
Number 6
Year 2016
Page from 767
Page to 775
Reviewed? Y
DOI http://dx.doi.org/10.1016/j.jval.2016.03.1837
Open Access N

Associations

People
Bilger, Marcel (Details)
External
Bee, Yong Mong (Singapore General Hospital, Singapore)
Dong, Di (Duke-NUS Graduate Medical School, Singapore)
Finkelstein, Eric (Duke-NUS Graduate Medical School, Singapore)
Ozdemir, Semra (Duke-NUS Graduate Medical School, Singapore)
Toh, Sue-Anne (National University Health System, Singapore)
Organization
Health Economics and Policy Group AB (Details)
Google Scholar: Search